# A Study of AL102 in Patients With Progressing Desmoid Tumors

Source: https://onco.cc/trials/nct04871282/  
OnCo record `nct04871282` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2/3 trial testing Varegacestat in desmoid tumour, active and no longer recruiting.

## Summary

A Study of AL102 in Patients With Progressing Desmoid Tumours is a phase 2/3 interventional study registered as NCT04871282, led by Immunome, and active but no longer recruiting on the registry. Official title: RINGSIDE: A Phase 2/3, Randomised, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumours. Planned enrolment is 198 participants (actual). The study started in 2021-09-01 and primary completion is expected in 2025-12-03. No results have been posted on ClinicalTrials.gov.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-11
- Also known as: RINGSIDE
- Tags: ctgov-ingest
- Registry id: NCT04871282
- Phase: 2/3
- Setting: RINGSIDE: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumors
- Sponsor: Immunome
- Enrolled: 198

## Sources

- ClinicalTrials.gov NCT04871282: https://clinicaltrials.gov/study/NCT04871282

## Connected records

- cancers: [Desmoid tumour](https://onco.cc/cancers/desmoid-tumour/)
- drugs: [Varegacestat](https://onco.cc/drugs/varegacestat/)
- companies: [Immunome](https://onco.cc/companies/immunome/)

---
JSON: https://onco.cc/api/v1/entities/nct04871282.json